Skip to content

Clinical trials

Kidney Failure, Chronic trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Failure, Chronic Country / region: Brazil Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20061
20073
20084
20093
20102
20113
20122
20132
20142
20152
20161
20192
20211
20225
20233
20244
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status9
Recruiting5
Withdrawn4
Terminated4
Suspended1
Active, not recruiting1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federal University of São Paulo4
University of Sao Paulo General Hospital4
Azidus Brasil3
Eledon Pharmaceuticals3
Hospital de Clinicas de Porto Alegre3
Ineos Healthcare Limited2
Universidade Católica de Pelotas2
University of Campinas, Brazil2
Ana Elizabeth Prado Lima Figueiredo1
Apellis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Failure, Chronic46
Renal Insufficiency, Chronic10
Hyperphosphatemia4
Kidney Diseases3
Renal Insufficiency3
Atherosclerosis2
Cardiovascular Diseases2
Coronary Artery Disease2
Diabetes Mellitus, Type 22
Peripheral Arterial Disease2

Trials

Showing 51 to 46 of 46. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.